SEC Form 4 · accession 0001140361-16-055391
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett Sandercock
Officer — Chief Financial Officer
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 10:34 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Feb 25, 2016 | S | 17,191 | $57.59 | D | 132,136 | D | |
| ResMed Common Stock | Feb 26, 2016 | S | 5,900 | $57.59 | D | 126,236 | D | |
| ResMed Common Stock | Feb 26, 2016 | S | 6,909 | $57.67 | D | 119,327 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $57.50 to $58.00. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.